Title:
がんの治療のためのトリプトファンヒドロキシラーゼ阻害剤
Document Type and Number:
Japanese Patent JP2013510092
Kind Code:
A
Abstract:
Methods and compositions for the treatment and/or management of cancer are disclosed, which comprise the use of tryptophan hydroxylase inhibitors.
Inventors:
Olavets Tamas
Application Number:
JP2012537220A
Publication Date:
March 21, 2013
Filing Date:
November 04, 2010
Export Citation:
Assignee:
Rexicon Pharmaceuticals, Inc.
International Classes:
A61K31/198; A61K31/341; A61K31/343; A61K31/405; A61K31/426; A61K31/44; A61K31/4965; A61K31/497; A61K31/505; A61K31/53; A61P35/00; A61P43/00; C07D307/83; C07D209/20; C07D213/74; C07D239/34; C07D241/20; C07D251/16; C07D277/20; C07D277/34; C07D307/68; C07D401/04; C07D403/04; C07D403/12; C07D405/12; C07D409/12; C07D413/12; C07D417/12
Attorney, Agent or Firm:
Patent Business Corporation Saegusa International Patent Office